Heat Biologics (HTBX) Shares Hit on Adverse HS-410 Combo Phase 2 Data in Invasive Bladder Cancer

December 1, 2016 8:20 AM EST Send to a Friend
Heat Biologics (Nasdaq: HTBX) shares are getting hit early Thursday after the company announced that it presented topline data from ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login